Wyss Zürich Logo with claim Wyss Zürich Logo with claim
WZRMTP Zuri Pharm Wysszurich keyvisual denovoskin Wyss Annual Event 2024 140 Falling Walls 1 Abb Sevensense Seervision Acquisition23 All projects of Wyss Zurich Slider Vacancies

Strategic partnership for innovative therapies

The Wyss Zurich Regenerative Medicine Technologies Platform of the University of Zurich and ZüriPharm AG have entered into a strategic partnership to support and accelerate the translation of innovative therapies from research to clinical application. 

denovoSkin™ authorized for Phase 3 clinical trial

Our alumni project, denovoSkin (now CUTISS AG), recently received the authorization from the European Medicines Agency for their lead product.

Annual Event 2024

This year, we explored the multi-dimensional concept of resilience.

Nanoflex: Falling Walls Winner

During the Falling Walls Summit on 7-9 November, Nanoflex was announced winner of the Engineering of the Future cluster for their innovative technology for interventional stroke treatment.

Sevensense acquired by ABB

Sevensense will continue its innovation in AI and 3D vision with ABB.

Seervision acquired by Q-SYS

Seervision joins forces with Q-SYS to bring together exceptional teams and expand intelligent collaboration solutions

26 Projects supported

with life changing impact in society and markets

We are hiring

Who we are

Wyss Zurich is a unique accelerator, embedded within the ETH Zurich and the University of Zurich, dedicated to the emerging fields of regenerative medicine and robotics, and medical devices/bionics technologies. We unite world-leading experts, pooling their knowledge and expertise, to form multidisciplinary teams.

News

Wysszurich keyvisual cenereg 19-12-2024

CeNeReg: Positive results reported in a Phase 2b trial in the regeneration of spinal cord of paraplegics

The clinical trial evaluated the safety and efficacy of NG101, a recombinant human antibody that neutralizes the growth-inhibiting protein Nogo-A, on recovery in patients with acute cervical...
Wyss Annual Event 2024 055 12-12-2024

Additional USD 60M raised by ANYbotics to drive scaling and expansion activities

With the additional financing, our alumni project, ANYmotion (now ANYbotics AG), will continue to scale globally and drive its expansion activities in the USA.
WZRMTP Zuri Pharm 11-12-2024

Strategic partnership between Wyss Zurich RMTP and ZüriPharm AG to promote innovative therapies

The Wyss Zurich Regenerative Medicine Technologies Platform (Wyss Zurich RMTP) of the University of Zurich and ZüriPharm AG have entered into a strategic partnership to support and accelerate the...
Organizational new

Organizational Setup

The Wyss Zurich Translational Center is run jointly by the ETH Zurich and University of Zurich, with infrastructure on both sides. The head office, technology platforms, and the projects are allocated at the Wyss Zurich Translational Center, which is the operational body. The Wyss Zurich Foundation is the approval and funding body.

Key Figures

26

Projects supported

700+

Jobs created

135 M+

(CHF) Total funding

350 M+

(CHF) Additional funding

Hansjoerg wyss gespraech 1400

Philanthropist Hansjörg Wyss

Hansjörg Wyss is a Swiss entrepreneur and philanthropist who dedicates his philanthropic activities to environmentalism, scientific research and translation. In Switzerland, his donations have already exceed more than half a billion Swiss Francs in less than ten years, to groundbreaking research projects within three different Wyss Centers or Academy in Zurich, Geneva, and Bern. This makes him the most generous private donor to the Swiss research and innovation landscape.